Devon Anderson v. HHS - Tdap, immune thrombocytopenic purpura (ITP) (2025)
Case summary [AI summaries can sometimes make mistakes]
On October 11, 2022, Devon Anderson filed a petition alleging that a Tdap vaccine administered on September 10, 2021 caused immune thrombocytopenic purpura and related sequelae. Respondent denied that the Tdap vaccine caused Ms.
Anderson's ITP, denied that she suffered residual effects for more than six months, and denied that her current condition was a vaccine-related sequela. The public stipulation does not provide platelet counts, bleeding symptoms, hospitalization, medication use, specialist visits, or recovery details.
On April 9, 2025, Chief Special Master Brian H. Corcoran adopted the parties' stipulation and awarded Ms.
Anderson a lump sum of $13,000.00 for all damages available under the Vaccine Act. A later supplemental decision awarded attorney's fees and costs, but that later award was for litigation expenses, not vaccine-injury compensation.
Ms. Anderson was represented by Simina Vourlis.